Lataa...
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
There is currently a lack of biological tools to study the replication cycle and pathogenesis of SARS-CoV-2, the etiological agent of COVID-19. Repurposing the existing tools, including antibodies of SARS-CoV, is an effective way to accelerate the development of therapeutics for COVID-19. Here, we e...
Tallennettuna:
| Julkaisussa: | bioRxiv |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Cold Spring Harbor Laboratory
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7402058/ https://ncbi.nlm.nih.gov/pubmed/32766589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.07.30.229377 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|